Findings from this project will identify urgently needed strategies for improving school-based mental health supports for adolescents with suicidal thoughts and behaviors to prevent suicide during resurgences of COVID-19 that force school closures.

We are interested in how people form evaluations of performance at work. Performance is an important outcome for organizations, but how we measure performance is complicated. We want to study how individuals assess other people's performance.

This study seeks to evaluate the impacts of our project on campus mental health, well-being, and resilience. The study will collect critical incident reports that illustrate examples of impactful activities at UNC-CH.

To compare current knowledge, attitudes, and prescribing behaviors for recurrent UTIs in women among providers according to 1. primary care specialty: internal medicine, family medicine, and obstetrics and gynecology. 2. provider type: physician, nurse practitioner, physician assistant, certified nurse midwife. 3. practice setting: rural vs urban, academic vs community.

This is a study focusing on the sound system of the P'urhepecha language.

This study is designed to test Baxdrostat's effect on patients with hypertension.

Analyze time expenditure of medical students through hourly logging, daily subjective happiness ratings, and performance on examinations.

This study will look at the current health statuses of members of the Lumbee tribe. Health statuses of other tribes who have federal recognition will be put together in order to compare them to those of the Lumbee. This study hopes to see what exactly federal recognition could potentially do for the Lumbee tribe when it comes to health if they were to receive it.

To determine in a randomized manner whether the addition of levocarnitine prophylaxis to asparaginase-containing regimens will decrease the incidence of conjugated hyperbilirubinemia (>3 mg/dL) during ALL induction therapy in adolescents and young adults (AYAs, age 15-39 years).

There are no current, approved therapies to treat children ages 2 to 5 with pediatric functional constipation (PFC). Therefore, we aim to evaluate whether linaclotide can be an effective and safe therapy for children with functional constipation (FC) in this age group.